Skip Navigation LinksHome > March 2012 - Volume 55 - Issue 1 > A Rational Approach to the Management of Recurrent or Persis...
Clinical Obstetrics & Gynecology:
doi: 10.1097/GRF.0b013e31824b9bc5
Ovarian Cancer

A Rational Approach to the Management of Recurrent or Persistent Ovarian Carcinoma


Collapse Box


Evidence supports the current paradigm for the management of patients with recurrent or persistent ovarian carcinoma. The paradigm requires that patients be classified as platinum-sensitive or platinum-resistant. Patients who achieve a complete response with platinum-based therapy and experience at least 6 months free from recurrence should be categorized as having chemosensitive disease and should be retreated with carboplatin-based doublets. Patients who progress while receiving treatment, whose best response is stable disease, or who experience a complete response of <6 months duration should be categorized as having chemoresistant disease and should be treated with a nonplatinum single agent.

© 2012 Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.